abdominal aortic aneurysm

临床试验

计划入组 10 人 · 首次发布于 2023 年 8 月 9 日

已完成

NCT04325373

Abdominal Aortic Aneurysm Surgery and Thrombosis

计划入组 40 人 · 首次发布于 2020 年 3 月 27 日

已完成

NCT00005526

Genetic Basis of Abdominal Aortic Aneurysm

首次发布于 2000 年 5 月 26 日

药物

查看全部 114 →

Small Molecule

Approved

Nimodipine(Nimotop, Nymalize)

生产企业：Banner pharmacaps inc, Barr laboratories inc，另有 2 家

相关疾病：Delayed Ischemic Neurological Deficit

C₂₁H₂₆N₂O₇ · Rx

Small Molecule

Approved

Eravacycline(Xerava)

相关疾病：Intraabdominal Infections

C₂₇H₃₁FN₄O₈ · Rx

Small Molecule

Approved

Hyoscine butylbromide(Buscopan)

相关疾病：Gastrointestinal spastic and hypermotility disorders, Infantile Hypertrophic Pyloric Stenosis，另有 9 项

C₂₁H₃₀NO₄ · Rx

机构

查看全部 42 →

THUBRIKAR AORTIC VALVE INC

United States

Bolton Medical, Inc.

United States

Artivion

United States

资讯

查看全部 870 →

8个月前

Metformin Enters Largest-Ever Clinical Trial for Abdominal Aortic Aneurysm Treatment

去年

Pila Pharma's XEN-D0501 Shows Promise in Preclinical Abdominal Aortic Aneurysm Study

去年

临床试验

Automatic Abdominal Aortic Aneurysm Diameter Measurement

Abdominal Aortic Aneurysm Surgery and Thrombosis

Genetic Basis of Abdominal Aortic Aneurysm

药物

Nimodipine(Nimotop, Nymalize)

Eravacycline(Xerava)

Hyoscine butylbromide(Buscopan)

机构

THUBRIKAR AORTIC VALVE INC

Bolton Medical, Inc.

Artivion

资讯

Metformin Enters Largest-Ever Clinical Trial for Abdominal Aortic Aneurysm Treatment

Pila Pharma's XEN-D0501 Shows Promise in Preclinical Abdominal Aortic Aneurysm Study

PILA PHARMA's XEN-D0501 Investigated for Abdominal Aortic Aneurysm Treatment in Preclinical Study